Brought to you by 
Lumara divests its women's health products to Perrigo ahead of acquisition by AMAG
23 Nov 2021
Executive Summary
Concurrent with AMAG Pharmaceuticals Inc.’s acquisition of women’s health firm Lumara Health Inc., Lumara is divesting three of its marketed assets to Irish pharmaco Perrigo Co. PLC.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Specialty Pharmaceuticals
-
Drug Delivery
- Site Specific
- Transdermal
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Lumara divests its women's health products to Perrigo ahead of acquisition by AMAG
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice